0078-0468-15 |
0078-0468 |
HUMAN PRESCRIPTION DRUG |
Exjade |
deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20051130 |
N/A |
NDA |
NDA021882 |
Novartis Pharmaceuticals Corporation |
DEFERASIROX |
125 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0468-15) |
0078-0469-15 |
0078-0469 |
HUMAN PRESCRIPTION DRUG |
Exjade |
deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20051130 |
N/A |
NDA |
NDA021882 |
Novartis Pharmaceuticals Corporation |
DEFERASIROX |
250 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15) |
0078-0470-15 |
0078-0470 |
HUMAN PRESCRIPTION DRUG |
Exjade |
deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20051130 |
N/A |
NDA |
NDA021882 |
Novartis Pharmaceuticals Corporation |
DEFERASIROX |
500 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0470-15) |